Recent evidence suggests that RGC32 overexpression promotes the invasion and migration of lung cancer cells by inducing EMT through the NF-κB signaling pathway (30) and that the knockout of RGC32 inhibits the growth, migration, and invasion of lung cancer cells (31). Here, RGCC is linked to lung carcinoma.